A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

Active:	Yes
Cancer Type:	Head and Neck Cancer	NCT ID:	NCT07219212
Trial Phases:	Phase I	Protocol IDs:	90301900HNC1001 (primary) NCI-2025-09717 2025 2025-522914-22-00 90301900HNC1001
Eligibility:	18 - 74 Years, Male and Female	Study Type:	Treatment
Study Sponsor:	Johnson & Johnson Enterprise Innovation Inc.
NCI Full Details:	http://clinicaltrials.gov/show/NCT07219212

Summary

This global, open-label, single arm, phase 1b study aims to learn more about whether a
treatment called JNJ-90301900 is safe and effective when injected directly into tumors,
along with standard chemotherapy and radiation therapy, for participants with head and
neck squamous cell cancer (HNSCC; a type of solid tumor that begins in outer tissue layer
of the mouth & throat).

Treatment Sites in Georgia

Emory University Hospital - Midtown
550 Peachtree Street NE
Atlanta, GA 30308
404-686-4411
www.emoryhealthcare.org

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.